Benchmark Financial Wealth Advisors, LLC Dynavax Technologies Corp Transaction History

Benchmark Financial Wealth Advisors, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Oct 15, 2020	SELL	$4.32 - $11.7 $43,200 - $117,000	-10,000 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$2.94 - $9.1 $29,400 - $91,000	10,000 New	10,000 $89,000

273

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.54B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Benchmark Financial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Benchmark Financial Wealth Advisors, LLC with notifications on news.